SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-23-000284
Filing Date
2023-11-02
Accepted
2023-11-02 11:21:53
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20230930.htm   iXBRL 10-Q 2207368
2 EX-31.1 lly-09302023x10qxexhibit311.htm EX-31.1 10591
3 EX-31.2 lly-09302023x10qxexhibit312.htm EX-31.2 10622
4 EX-32 lly-09302023x10qxexhibit32.htm EX-32 7082
  Complete submission text file 0000059478-23-000284.txt   11269553

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20230930.xsd EX-101.SCH 50180
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20230930_cal.xml EX-101.CAL 70683
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20230930_def.xml EX-101.DEF 286858
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20230930_lab.xml EX-101.LAB 726800
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20230930_pre.xml EX-101.PRE 469180
68 EXTRACTED XBRL INSTANCE DOCUMENT lly-20230930_htm.xml XML 2642337
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 231370760
SIC: 2834 Pharmaceutical Preparations